DavidReedBenzigerMD

PubMed

• 22 citations
  Single-dose pharmacokinetics of daptomycin in pediatric patients 3-24 months of age.
  John S. Bradley, David Benziger, Paula M. Bokesch, Richard F. Jacobs> ;The Pediatric Infectious Disease Journal. 2014 Sep 1
• 35 citations
  Single-dose pharmacokinetics and tolerability of daptomycin 8 to 10 mg/kg in children aged 2 to 6 years with suspected or proved Gram-positive infections.
  Susan M. Abdel-Rahman, Gurudatt Chandorkar, Ronda L. Akins, John S. Bradley, Richard F. Jacobs, Julie Donovan, David Benziger> ;The Pediatric Infectious Disease Journal. 2011 Aug 1
• 14 citations
  Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis.
  David Benziger, Peter Pertel, J Donovan, S Yankelev, R J Schwab, S K Swan, Christopher P. Cannon> ;Clinical Nephrology. 2011 Jan 1
• 50 citations
  Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections.
  Susan M. Abdel-Rahman, David Benziger, Richard F. Jacobs, Hasan S. Jafri, Erica Fischer Hong, Gregory L. Kearns> ;The Pediatric Infectious Disease Journal. 2008 Apr 1
• 246 citations
  Pharmacokinetics and Tolerability of Daptomycin at Doses up to 12 Milligrams per Kilogram of Body Weight Once Daily in Healthy Volunteers
  Mark Benvenuto, David Benziger, Sara Yankelev, Gloria Vigliani> ;Antimicrobial Agents and Chemotherapy. 2006 Oct 1
• A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria.
  Katz, D. E., Lindfield, K. C., Steenbergen, J. N., Benziger, D. P., Blackerby, K. J., Knapp, A. G., Martone, W. J.> ;Int J Clin Pract. 2008 Sep
• Join now to see all